Pradžia › Šizofrenija › Merilendas
Šizofrenija klinikiniai tyrimai Merilendas
18 tyrimai dėl Šizofrenija ieško dalyvių vietose Merilendas.
Miestai Merilendas
Oficialus tyrimo tekstas (anglų kalba)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- University of Maryland, Baltimore, Baltimore
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 59 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07853807Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- The Johns Hopkins Hospital, Baltimore
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07101094Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0192, Gaithersburg
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07114874A Study of Brenipatide in Adult Participants With Schizophrenia
- CBH Health, Gaithersburg
Renkami dalyviai2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07410507A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CBH Health LLC., dba CenExel Gaithersburg MD, Gaithersburg
Renkami dalyviai1 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-17 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cbh Health - Gaithersburg /ID# 272932, Gaithersburg
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-15 · NCT0714591852-week Open Label Safety-Tolerability Study
- CenExel Gaithersburg, Gaithersburg
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Gaithersburg
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel CBH, Gaithersburg
Renkami dalyviai2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07191483Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of Maryland School of Medicine, Baltimore
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-04 · NCT05208190Synbiotic Compound to Reduce Symptoms of Schizophrenia
- Sheppard Pratt Health System, Batlimore
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-07 · NCT04226898NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Gaithersburg
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-06 · NCT06963034White Matter Plasticity in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
- University of Maryland Baltimore - Maryland Psychiatric Research Center, Catonsville
Renkami dalyviai
Amžius nuo 15 iki 45 · Visoms lytims · Atnaujinta 2026-02-20 · NCT06641297TMS for Inhibition Enhancement in Schizophrenia
- Maryland Psychiatric Research Center, Catonsville
Renkami dalyviai
Amžius nuo 18 iki 45 · Visoms lytims · Atnaujinta 2026-02-13 · NCT06155682CBT-CP for Veterans With SMI
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-09 · NCT06758414Study of ALTO-101 in Patients With Schizophrenia
- Site 5062, Gaithersburg
Renkami dalyviai2 fazė
Amžius nuo 21 iki 55 · Visoms lytims · Atnaujinta 2025-12-26 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Gaithersburg
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2024-12-19 · NCT05184335Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.